4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm)
Key Takeaways
- DKA is characterized by hyperglycemia (> 250 mg/dL), metabolic acidosis (pH < 7.30, bicarb < 18 mEq/L), high anion gap (> 10-12 mEq/L), and serum ketones, whereas HHS presents with severe hyperglycemia (> 600 mg/dL), serum osmolality > 320 mOsm/kg, and minimal acidosis.
- Potassium replacement is mandatory prior to initiating insulin therapy; if serum K+ is < 3.3 mEq/L, insulin must be withheld until potassium is restored to > 3.3 mEq/L.
- Regular insulin is infused at 0.1 units/kg/hr; once glucose reaches 200-250 mg/dL in DKA (or 300 mg/dL in HHS), dextrose (D5W/D10W) must be added to IV fluids while maintaining insulin to clear ketoacidosis.
- Rapid drop in serum osmolality increases the risk of fatal cerebral edema; serum glucose reduction must be limited to 50-75 mg/dL/hr.
- Thyroid storm treatment requires a precise sequential medical strategy: Beta-blocker -> PTU/Methimazole -> Iodine (at least 1 hour post-PTU) -> Hydrocortisone.
4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm)
Diabetic Ketoacidosis (DKA) vs. Hyperosmolar Hyperglycemic State (HHS)
Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) represent extreme decompensations of diabetes mellitus. While both involve insulin dysfunction and severe hyperglycemia, their underlying pathophysiology, biochemical markers, and clinical presentations differ markedly.
Pathophysiology & Diagnostic Criteria
- DKA: Results from an absolute deficiency of insulin combined with an excess of counter-regulatory hormones (glucagon, catecholamines, cortisol, growth hormone). This shifts cellular metabolism to lipolysis, generating free fatty acids converted by the liver into ketone bodies ($\beta$-hydroxybutyrate and acetoacetate). This produces metabolic acidosis with an elevated anion gap ($> 10-12\text{ mEq/L}$, calculated as $[\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-])$).
- HHS: Results from a relative insulin deficiency. There is sufficient circulating insulin to prevent significant lipolysis and ketogenesis, but insufficient insulin to facilitate peripheral glucose uptake. Consequently, extreme hyperglycemia develops, producing massive osmotic diuresis, profound dehydration, and serum hyperosmolality ($> 320\text{ mOsm/kg}$).
Diagnostic Matrix: DKA vs. HHS
| Diagnostic Parameter | Mild DKA | Moderate DKA | Severe DKA | Hyperosmolar Hyperglycemic State (HHS) |
|---|---|---|---|---|
| Blood Glucose | $> 250\text{ mg/dL}$ | $> 250\text{ mg/dL}$ | $> 250\text{ mg/dL}$ | $> 600\text{ mg/dL}$ (often $> 1000\text{ mg/dL}$) |
| Arterial/Venous pH | $7.25 - 7.30$ | $7.00 - 7.24$ | $< 7.00$ | $> 7.30$ |
| Serum Bicarbonate | $15 - 18\text{ mEq/L}$ | $10 - < 15\text{ mEq/L}$ | $< 10\text{ mEq/L}$ | $> 18\text{ mEq/L}$ |
| Urine/Serum Ketones | Positive | Positive | Positive | Negative or trace |
| Serum Osmolality | Variable | Variable | Variable | $> 320\text{ mOsm/kg}$ |
| Anion Gap | $> 10\text{ mEq/L}$ | $> 12\text{ mEq/L}$ | $> 12\text{ mEq/L}$ | Variable (usually normal $< 12$) |
| Mental Status | Alert | Alert / Drowsy | Stupor / Coma | Stupor / Coma |
Fluid Resuscitation & Glucose Titration
Fluid replacement is the initial therapeutic priority to restore intravascular volume, improve renal perfusion, and reduce serum glucose through dilution.
- Initial Fluid Resuscitation: Infuse $1.0 - 1.5\text{ L}$ (or $10-20\text{ mL/kg}$) of $0.9%$ Normal Saline over the first hour.
- Subsequent Fluid Selection: Calculate corrected sodium ($[\text{Na}^+]{\text{corrected}} = [\text{Na}^+]{\text{measured}} + 0.016 \times (\text{Glucose} - 100)$):
- If corrected $\text{Na}^+$ is normal or high, switch to $0.45%$ Normal Saline at $250 - 500\text{ mL/hr}$.
- If corrected $\text{Na}^+$ is low, continue $0.9%$ Normal Saline at $250 - 500\text{ mL/hr}$.
- Dextrose Addition: When blood glucose drops to $200 - 250\text{ mg/dL}$ in DKA (or $300\text{ mg/dL}$ in HHS), add $5%$ or $10%$ Dextrose ($D_5W$ or $D_5 0.45%$ NS) to IV fluids. Do not stop the insulin drip at this stage! Dextrose co-infusion allows continuous insulin administration to suppress ketoacidosis while preventing hypoglycemia.
Critical Potassium Replacement Rules
Insulin drives potassium from the extracellular space into cells via $Na^+/K^+$ ATPase activation. Administering insulin during severe hypokalemia causes precipitous shifts leading to lethal cardiac arrhythmias or respiratory muscle paralysis.
Mandatory Potassium Rules Prior to Insulin Drip
- If Serum $\text{K}^+ < 3.3\text{ mEq/L}$: HOLD INSULIN THERAPY! Administer $\text{KCl} 20-40\text{ mEq/hr}$ IV until serum potassium exceeds $3.3\text{ mEq/L}$. Only then may insulin be initiated.
- If Serum $\text{K}^+ = 3.3 - 5.3\text{ mEq/L}$: Initiate insulin infusion AND add $20 - 30\text{ mEq } \text{KCl}$ per liter of IV fluid to maintain serum potassium between $4.0 - 5.0\text{ mEq/L}$.
- If Serum $\text{K}^+ > 5.3\text{ mEq/L}$: Initiate insulin infusion without IV potassium; recheck serum $\text{K}^+$ every 1-2 hours.
Insulin Infusion Dosing
Administer Regular Insulin as a continuous IV infusion at $0.1\text{ units/kg/hr}$ (or $0.14\text{ units/kg/hr}$ without an initial bolus). Target a rate of glucose decline of $50 - 75\text{ mg/dL per hour}$.
Cerebral Edema Risk & Prevention
Rapid decreases in serum glucose and effective osmolality create an osmotic gradient across the blood-brain barrier, driving water into brain cells and causing acute cerebral edema. Cerebral edema is a major cause of mortality during DKA/HHS treatment, particularly in pediatric and young adult populations.
- Prevention: Limit the rate of glucose reduction to $< 75-100\text{ mg/dL/hr}$ and effective osmolality reduction to $< 3\text{ mOsm/kg/hr}$.
- Clinical Warning Signs: New-onset headache, lethargy, bradycardia and hypertension (Cushing's triad), confusion, or decreased GCS score during transport.
- Immediate Treatment: Administer Mannitol ($0.5 - 1.0\text{ g/kg}$ IV over 15 min) or $3%$ Hypertonic Saline ($2.5 - 5.0\text{ mL/kg}$ IV over 10-15 min). Elevate head of bed $30^\circ$.
Acute Adrenal Crisis
Acute adrenal crisis is a life-threatening endocrine emergency resulting from an absolute deficiency of glucocorticoids (cortisol) and mineralocorticoids (aldosterone). It occurs in patients with primary adrenal insufficiency (Addison's disease) or secondary adrenal failure (hypothalamic-pituitary axis suppression) exposed to physiological stress (infection, trauma, surgery, or abrupt steroid withdrawal).
Clinical Manifestations
- Refractory hypotension and vasopressor-resistant shock
- Severe abdominal pain, fever, nausea, vomiting
- Biochemical hallmarks: Hyponatremia, Hyperkalemia, Hypoglycemia, and non-anion gap metabolic acidosis.
Transport Management Protocol
- Steroid Replacement: Administer Hydrocortisone $100\text{ mg}$ IV push immediately, followed by $100-200\text{ mg}$ over 24 hours (or $50\text{ mg}$ IV Q6H). Hydrocortisone provides both glucocorticoid and mineralocorticoid coverage.
- Alternative: If formal cosyntropin stimulation testing is planned post-transport, administer Dexamethasone $4\text{ mg}$ IV push, as it does not cross-react with cortisol assays.
- Volume & Glucose Resuscitation: Rapidly infuse $D_5NS$ crystalloid boluses to restore intravascular volume and correct hypoglycemia.
Thyroid Storm (Thyrotoxic Crisis)
Thyroid storm is an extreme, life-threatening manifestation of thyrotoxicosis characterized by hypermetabolism and systemic decompensation. Triggers include infections, trauma, surgery, or iodine exposure in patients with underlying Graves' disease or toxic multinodular goiter.
Clinical Manifestations
- Hyperthermia: Extreme fever ($> 40.0^\circ\text{C} / 104.0^\circ\text{F}$).
- Cardiovascular: Severe tachycardia, high-output heart failure, atrial fibrillation with rapid ventricular response.
- Central Nervous System: Extreme agitation, delirium, psychosis, or coma.
- Gastrointestinal: Diarrhea, jaundice, abdominal pain.
Four-Step Sequential Blockade Protocol for Thyroid Storm
Pharmacological management of thyroid storm requires a strict multi-drug strategy executed in a precise order:
| Step | Drug & Dosage | Pharmacological Mechanism | Clinical Rationale |
|---|---|---|---|
| 1. Beta-Blocker | Propranolol: $1 - 2\text{ mg}$ slow IV push (or $60-80\text{ mg}$ PO Q6H) | Blocks $\beta_1/\beta_2$ receptors; inhibits peripheral conversion of $T_4 \rightarrow T_3$ | Controls hyperadrenergic state (tachycardia, fever) |
| 2. Antithyroid Synthesis Inhibitor | Propylthiouracil (PTU): $200-400\text{ mg}$ PO/NG Q6H (or Methimazole $20\text{ mg}$ PO Q6H) | Inhibits thyroid peroxidase, blocking new hormone synthesis | PTU also blocks peripheral conversion of $T_4 \rightarrow T_3$ |
| 3. Iodine Administration | Potassium Iodide (SSKI): 5 drops PO Q6H (Give $\ge 1\text{ hour}$ AFTER Step 2) | Blocks release of preformed hormone (Wolff-Chaikoff effect) | Must give AFTER Step 2 to prevent iodine from fueling new synthesis |
| 4. Glucocorticoids | Hydrocortisone: $100\text{ mg}$ IV Q8H (or Dexamethasone $2\text{ mg}$ IV Q6H) | Inhibits $T_4 \rightarrow T_3$ conversion; treats relative adrenal exhaustion | Protects against co-existing adrenal insufficiency |
Critical Caution: When managing fever in thyroid storm, AVOID ASPIRIN / SALICYLATES. Salicylates displace thyroid hormones ($T_3/T_4$) from thyroid-binding globulin (TBG), dramatically raising free serum thyroid hormone levels and worsening the crisis. Use Acetaminophen and active cooling blankets.
Prior to initiating a continuous regular insulin infusion in a patient presenting with severe Diabetic Ketoacidosis (DKA), which laboratory measurement must be confirmed?
During fluid resuscitation of a patient with DKA, what IV fluid modification is required when blood glucose reaches 200 to 250 mg/dL?
In the sequential pharmacological management of Thyroid Storm, why must potassium iodide (SSKI) be administered at least one hour AFTER antithyroid medications (PTU or methimazole)?